NEXT
Sign in to follow
Search Results

0 results for 'Boehringer Ingelheim'

You can use to get even better search results
August 26, 2019 | Daily Business Review

Florida Getting Spillover Pradaxa Blood-Thinner Litigation, Once Reserved for Connecticut

Co-national leads for litigation against Boehringer Ingelheim Pharmaceuticals Inc., C. Andrew Childers of Childers, Schlueter & Smith in Atlanta and Neal Moskow of Ury & Moskow in Fairfield, Connecticut, have branched out with two Florida lawsuits in an attempt to avoid overcrowded Connecticut dockets.
4 minute read
August 23, 2019 | The American Lawyer

Deal Watch: Paul Weiss, Sullivan Cromwell, Linklaters Lead Bayer/Elanco Deal

A bevy of Am Law 200 firms advised on the latest big deals: Elanco bought the animal health division of Bayer AG, VMWare makes two acquisitions, Hasbro buys up eOne and Simply Food gets nutritious.
5 minute read
May 30, 2019 | National Law Journal

Products Liability/Mass Torts Winner: Covington & Burling

A young, dynamic, diverse team, top-flight trial capabilities and having a knack for crafting complex facts into understandable stories are the keys to success."
4 minute read
May 21, 2019 | Connecticut Law Tribune

Hartford Jury Returns $542K Verdict Against Boehringer Ingelheim in Pradaxa Blood Thinner Case

The six-person jury found in favor of 81-year-old plaintiff Eugene Roberto, whose attorneys said suffered life-threatening bleeding after he began taking the drug. Pharmaceutical giant Boehringer Ingelheim plans to appeal the verdict.
3 minute read
May 17, 2019 | Law.com

Tips from the Top: 8 GCs Share How to Get Ahead

We asked the former general counsel of Starbucks, Delta Airlines, AIG and other major companies for their best career advice. Here's what they had to say.
2 minute read
May 15, 2019 | Litigation Daily

AbbVie, Boehringer Settle Humira Patent Fight

Under the agreement, Boehringer will to pay AbbVie royalties for licensing its Humira patents and agreed to acknowledges the validity and enforceability of the patents, AbbVie said.
3 minute read
May 15, 2019 | Delaware Business Court Insider

AbbVie, Boehringer Settle Humira Patent Dispute in U.S.

Under the agreement, Boehringer will to pay AbbVie royalties for licensing its Humira patents and agreed to acknowledges the validity and enforceability of the patents, AbbVie said.
3 minute read
May 14, 2019 | Law.com

Skilled in the Art: Pharma Patents: The Good, the Bad, and the Vaguely Familiar + FTC Cracks on DOJ

Three pharma patent bombs exploded this week, and we have a look at the law firms on the front lines.
9 minute read
May 07, 2019 | Daily Business Review

Half Full? South Florida Plaintiff Leads Asthma Inhaler Class Action

The lawsuit against Boehringer Ingelheim Pharmaceuticals claims its Combivent Respimat inhaler offers far fewer doses than advertised.
3 minute read
May 07, 2019 | Connecticut Law Tribune

Class Action Claims Boehringer Ingelheim Misled Users About Popular Asthma Inhaler

Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has been hit with a prospective class action lawsuit that alleges its Combivent asthma inhaler provides far less than the number of advertised doses.
3 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • 2024 Report: State of AI in Legal

    Brought to you by Ironclad

    Download Now

  • Blueprint for Successful Second Request Document Review

    Brought to you by Integreon

    Download Now

  • Employee Happiness Playbook: The 3 R's for Business Success in 2024

    Brought to you by Amazing Workplace, Inc.

    Download Now

  • The Positive Impact of AI at Small Law Firms: 4 Key Insights

    Brought to you by LexisNexis®

    Download Now